首页> 外国专利> Otti synthesis with temperature reversible condensation, including polyoxypropylene and polyoxyethylene polymers and a multitubular anti-inflammatory cortisol, lasted for five days after sintering through the membrane. A unified administrative body

Otti synthesis with temperature reversible condensation, including polyoxypropylene and polyoxyethylene polymers and a multitubular anti-inflammatory cortisol, lasted for five days after sintering through the membrane. A unified administrative body

机译：通过温度可逆缩合的奥蒂合成，包括聚氧化丙烯和聚氧化乙烯聚合物以及多管抗炎皮质醇，在通过膜烧结后持续了五天。统一的行政机构

页面导航

摘要
著录项

摘要

Formulation comprising substantially lower degradation products of methylprednisolone OR dexamethasone, prednisolone, and two or more selected characteristics of these corticosteroids;Corticosteroids such as multiparticulada, Copolymer, sterile water, Colony Forming Units and Microbiological and Endotoxin; use otic.

机译：制剂，包含甲基强的松龙或地塞米松，泼尼松龙的降解产物，以及这些皮质类固醇的两种或更多种选定的特征;皮质类固醇，例如多颗粒，共聚物，无菌水，菌落形成单位和微生物和内毒素;使用耳语。

著录项

公开/公告号CL2009001178A1

专利类型
公开/公告日2010-06-04

原文格式PDF
申请/专利权人 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;OTONOMY INC.;
展开▼

申请/专利号CL20090001178
发明设计人 JAY LICHTER;BENEDIKT VOLLRATH;ANDREW M. TRAMMEL;SERGIO G. DURON;FABRICE PIU;LUIS A. DELLAMARY;QIANG YE;CARL LEBEL;MICHAEL CHRISTOPHER SCAIFE;JEFFREY P. HARRIS;
展开▼

申请日2009-05-14
分类号A61K31/573;A61P27/16;
国家 CL
入库时间 2022-08-21 18:47:16